Senate Committee Hearing 110-375, Examining FDA Follow-On Biologics

Senate Committee on Health, Education, Labor, and Pensions,
March 8, 2007

HEARING OF THE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS 

UNITED STATES SENATE 
ONE HUNDRED TENTH CONGRESS 
FIRST SESSION 

ON
EXAMINING FOOD AND DRUG ADMINISTRATION FOLLOW-ON BIOLOGICS, GENERALLY REFERRED TO AS A BIOTECHNOLOGY-DERIVED PROTEIN DRUG (OR BIOLOGIC) THAT IS COMPARABLE TO A NOVEL, PREVIOUSLY APPROVED BIOLOGIC AND…

Read More